{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T08:48:19Z","timestamp":1758444499761,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.xphs.2020.09.041","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T11:07:00Z","timestamp":1601982420000},"page":"807-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paper 2. Epigallocatechin Gallate and Tannic Acid Based Formulations of Finasteride for Dermal Administration and Chemoembolization"],"prefix":"10.1016","volume":"110","author":[{"given":"John","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2020.09.041_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.steroids.2009.10.005","article-title":"An overview on 5\u03b1-reductase inhibitors","volume":"75","author":"Aggarwal","year":"2010","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.xphs.2020.09.041_bib2","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.24028","article-title":"Topical formulations containing finasteride. Part I: in vitro permeation\/penetration study and in vivo pharmacokinetics in hairless rat","volume":"103","author":"Monti","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.041_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0015-0282(00)00600-2","article-title":"Lack of effect of topical finasteride suggests an endocrine role for dihydrotestosterone","volume":"74","author":"Price","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xphs.2020.09.041_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejps.2016.03.015","article-title":"Transdermal film-loaded finasteride microplates to enhance drug skin permeation: two-step optimization study","volume":"88","author":"Ahmed","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.041_bib5","first-page":"1","article-title":"Enhanced follicular delivery of finasteride to human scalp skin using heat and chemical penetration enhancers","volume":"37","author":"Farah","year":"2020","journal-title":"Pharm Res (N Y)"},{"issue":"3\u20134","key":"10.1016\/j.xphs.2020.09.041_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01105079","article-title":"Human scalp hair follicle development from birth to adulthood: statistical study with special regard to putative stem cells in the bulge and proliferating cells in the matrix","volume":"287","author":"de Viragh","year":"1995","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.xphs.2020.09.041_bib7","first-page":"1209","article-title":"Finasteride enhances stem cell signals of human dermal papilla cells","volume":"33","author":"Rattanachitthawat","year":"2019","journal-title":"In\u00a0Vivo (Brooklyn)"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.041_bib8","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1002\/jps.23715","article-title":"Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia","volume":"102","author":"Pupe","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2020.09.041_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1148\/radiol.13122803","article-title":"Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate-a prospective, randomized, and controlled clinical trial","volume":"270","author":"Gao","year":"2014","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.041_bib10","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s00270-017-1700-7","article-title":"Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia","volume":"40","author":"Bagla","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.xphs.2020.09.041_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920917573","article-title":"Large inoperable leiomyosarcoma of the prostate: treated by transcatheter arterial chemoembolization with drug-eluting microspheres","volume":"12","author":"Wang","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.041_bib12","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1039\/C9BM01775E","article-title":"Development of finasteride\/PHBV@polyvinyl alcohol\/chitosan reservoir-type microspheres as a potential embolic agent: from in vitro evaluation to animal study","volume":"8","author":"Li","year":"2020","journal-title":"Biomater Sci"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.041_bib13","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.xphs.2016.06.027","article-title":"The effective solubilization of hydrophobic drugs using epigallocatechin gallate or tannic acid-based formulations","volume":"105","author":"Jackson","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2020.09.041_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0738-081X(89)90003-5","article-title":"Dermatologic vehicles","volume":"7","author":"Ricciatti-Sibbald","year":"1989","journal-title":"Clin Dermatol"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.041_bib15","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/acs.molpharmaceut.7b00348","article-title":"Gel-like TPGS-based microemulsions for imiquimod dermal delivery: role of mesostructure on the uptake and distribution into the skin","volume":"14","author":"Tel\u00f2","year":"2017","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2020.09.041_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-015-1566-y","article-title":"Colloidal carriers of isotretinoin for topical acne treatment: skin uptake, ATR-FTIR and in\u00a0vitro cytotoxicity studies","volume":"307","author":"G\u00fcrb\u00fcz","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.041_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/lsm.23013","article-title":"Topical delivery of vismodegib using ablative fractional laser and micro-emulsion formulation in\u00a0vitro","volume":"51","author":"Olesen","year":"2019","journal-title":"Lasers Surg Med"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2020.09.041_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpharm.2010.07.008","article-title":"Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis","volume":"398","author":"Pople","year":"2010","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.041_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2014.12.043","article-title":"Development of a protective dermal drug delivery system for therapeutic DNAzymes","volume":"479","author":"Marquardt","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.09.041_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.colsurfb.2013.07.014","article-title":"Close-packed vesicles for diclofenac skin delivery and fibroblast targeting","volume":"111","author":"Manca","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2020.09.041_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2017.03.091","article-title":"Dermal absorption behavior of fluorescent molecules in nanoparticles on human and porcine skin models","volume":"524","author":"Debotton","year":"2017","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2020.09.041_bib22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1208\/s12249-016-0554-7","article-title":"Lipid- and polymer-based nanostructures for cutaneous delivery of curcumin","volume":"18","author":"Caon","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2020.09.041_bib23","first-page":"1091","article-title":"Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"vol. 5","author":"Zumstein","year":"2019"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.041_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12894-019-0440-1","article-title":"Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis","volume":"19","author":"Jiang","year":"2019","journal-title":"BMC Urol"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.041_bib25","first-page":"2409","article-title":"Development of finasteride polymer microspheres for systemic application in androgenic alopecia","volume":"43","author":"Kim","year":"2019","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1016\/j.xphs.2020.09.041_bib26","first-page":"804","article-title":"Liquid gentamicin in bone cement spacers: in\u00a0vivo antibiotic release and systemic safety in two-stage revision of infected hip arthroplasty","volume":"66","author":"Hsieh","year":"2009","journal-title":"J\u00a0Trauma"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.041_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13346-011-0015-5","article-title":"The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength","volume":"1","author":"Jackson","year":"2011","journal-title":"Drug Deliv Transl Res"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2020.09.041_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2003.10.010","article-title":"The characterization of novel polymeric paste formulations for intratumoral delivery","volume":"270","author":"Jackson","year":"2004","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2020.09.041_bib29","first-page":"843","article-title":"Histologic long-term follow-up after embolization with polyvinyl alcohol particles","volume":"16","author":"Davidson","year":"1995","journal-title":"Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.041_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0046-8177(88)80204-1","article-title":"Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis","volume":"19","author":"Tomashefski","year":"1988","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.xphs.2020.09.041_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002800050903","article-title":"Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin","volume":"43","author":"Dvorakova","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.041_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2478\/acph-2014-0017","article-title":"In\u00a0vivo human skin penetration of (-)-epigallocatechin-3-gallate from topical formulations","volume":"64","author":"Scalia","year":"2014","journal-title":"Acta Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.041_bib33","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1208\/s12249-017-0718-0","article-title":"Skin delivery of EGCG and silibinin: potential of peptide dendrimers for enhanced skin permeation and deposition","volume":"18","author":"Shetty","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.041_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fct.2005.11.003","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.041_bib35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11095-010-0292-6","article-title":"The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal","volume":"28","author":"Bin Choy","year":"2011","journal-title":"Pharm Res (N Y)"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.041_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0305-4179(95)90784-W","article-title":"Tannic acid as a topical agent in burns: historical considerations and implications for new developments","volume":"21","author":"Hupkens","year":"1995","journal-title":"Burns"},{"key":"10.1016\/j.xphs.2020.09.041_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2147\/IJN.S154797","article-title":"Tannic acid-modified silver nanoparticles for wound healing: the importance of size","volume":"13","author":"Orlowski","year":"2018","journal-title":"Int. J. Nanomed"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.041_bib38","first-page":"466","article-title":"A\u00a0comparison of topical tannic acid versus iontophoresis in the medical treatment of palmar hyperhidrosis","volume":"37","author":"Goh","year":"1996","journal-title":"Singapore Med J"},{"key":"10.1016\/j.xphs.2020.09.041_bib39","series-title":"Antitumor-Promoting Activities of Tannic Acid, Ellagic Acid, and Several Gallic Acid Derivatives in Mouse Skin BT - Plant Polyphenols: Synthesis, Properties, Significance","first-page":"783","author":"Perchellet","year":"1992"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:32:00Z","timestamp":1758360720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920305724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022354920305724"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.041","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paper 2. Epigallocatechin Gallate and Tannic Acid Based Formulations of Finasteride for Dermal Administration and Chemoembolization","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}]}}